"Shaw Cancer Center provides high-quality, compassionate cancer care that's close to home and Jack's Place Cancer Caring House for those who need lodging during treatments. Our highly trained cancer specialists utilize the most advanced technology, along with the healing powers of nature, compassion, fitness and nutrition to treat a variety of cancers, including breast cancer, prostate cancer and lung cancer. With an innovative, holistic approach, cancer patients are empowered to become cancer survivors."

During the past decade, Shaw Cancer Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 33 clinical trials were completed, i.e. on average, 275% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 11 clinical trials were completed. i.e. 275% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shaw Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 18 trials, followed by "National Cancer Institute (NCI)" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "Radiation Therapy Oncology Group" with 4 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shaw Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NRG Oncology" with 5 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Shaw Cancer Center" are "Breast Cancer" (11 trials), "Prostate Cancer" (5 trials), "Breast Carcinoma" (2 trials), "Breast Ductal Carcinoma In Situ" (2 trials) and "Clear Cell Renal Cell Carcinoma" (2 trials). Many other conditions were trialed in "Shaw Cancer Center" in a lesser frequency.

Most popular intervention types in "Shaw Cancer Center" are "Drug" (45 trials), "Other" (25 trials), "Biological" (17 trials), "Radiation" (17 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (13 trials), "Quality-of-Life Assessment" (9 trials), "Bevacizumab" (8 trials), "Radiation Therapy" (7 trials) and "docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Shaw Cancer Center" are 25 trials for "All" genders, 20 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Shaw Cancer Center". 1 are not yet recruiting, 6 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Shaw Cancer Center, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Shaw Cancer Center, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".